Senior Investment Analyst

About The Department

At Novo Nordisk, we want to make a difference. For more than 100 years, we have led the way in diabetes care. Being part of Novo Nordisk allows our employees to embark on the opportunity to help improve the quality of life for millions of people around the world.

At Novo Nordisk, we want to make a difference. For more than 100 years, we have led the way in diabetes care. Being part of Novo Nordisk allows our employees to embark on the opportunity to help improve the quality of life for millions of people around the world.

In NC, we operate three pharmaceutical manufacturing facilities that are responsible for fulfilling different steps in our injectable and oral treatment supply chains. Our Product Supply Aseptic Manufacturing (PS AM) facility in Clayton, NC is a 457,000 square foot aseptic "fill and finish" site that is responsible for producing innovative, injectable diabetes and obesity treatments. At PS AM, you’ll join a global network of manufacturing professionals who are passionate about what they do.

• Leading pay and annual performance bonus for all positions
• All employees enjoy generous paid time off including 14 paid holidays
• Health Insurance, Dental Insurance, Vision Insurance – effective day one
• Guaranteed 8% 401K contribution plus individual company match option
• Family Focused Benefits including 14 weeks paid parental & 6 weeks paid family medical leave
• Free access to Novo Nordisk-marketed pharmaceutical products
• Tuition Assistance
• Life & Disability Insurance
• Employee Referral Awards

At Novo Nordisk, you will find opportunities, resources, and mentorship to help grow and build your career. Are you ready to realize your potential? Join Team Novo Nordisk and help us make what matters.

Provides financial and analytical support across the investment lifecycle for DPM US, helping enable effective capital allocation and portfolio decision‑making at Novo Nordisk. The role supports development and evaluation of business cases, portfolio transparency, month‑end investment reporting, and adherence to investment governance standards through robust analysis and accurate data management. This position contributes to value realization, portfolio visibility, and continuous improvement of investment management practices through application of the PEM model and effective use of Clarity.

Reports to Director or above. Interacts with project sponsors, leadership teams, Finance, Engineering, Production, and Portfolio Management stakeholders.

• Act as a finance partner supporting investment decision‑making at Novo Nordisk by providing structured financial analysis and insights across the investment lifecycle
• Support development and evaluation of business cases in alignment with Novo Nordisk's Project Execution Model (PEM model), ensuring financial assumptions, cost estimates, risks, and expected benefits are robust and consistent
• Perform detailed financial analysis of investment opportunities, including scenario analysis, sensitivity analysis, and risk assessments to support informed decision‑making
• Ensure adherence to Novo Nordisk investment governance standards by supporting consistent application of policies, processes, and approval requirements
• Maintain and update investment data in Clarity (portfolio management system), ensuring completeness, accuracy, and alignment with approved business cases and project timelines
• Support consolidation and reconciliation of investment financials as part of the month‑end close process, ensuring accurate and timely reporting
• Prepare investment reporting and analysis, highlighting deviations from plan, key drivers, risks, and opportunities for cost optimization or value improvement
• Support transparency of the investment portfolio by tracking project progress, financial phasing, and alignment with strategic priorities
• Collaborate with project teams, Engineering, Finance, and Operations to ensure financial assumptions reflect operational reality and evolving project conditions
• Identify inconsistencies or risks in financial data, assumptions, or project execution and elevate issues…